Contract Notice Detail

Summary Information

Summary Information
38,112.800000 Euro
 
45027224 
Aquisição do medicamento RAMUCIRUMAB [10 MG/ ML; 50 ML; SOL INJ; FRS], ao abrigo do CPA 2023/491 
Tendering Phase
Awarded
Aquisição do medicamento RAMUCIRUMAB [10 MG/ ML; 50 ML; SOL INJ; FRS], ao abrigo do CPA 2023/491 
VortalGOV - Acquisition under a Framework Agreement (via Direct Award) 
Lot NameLot Base PriceExpected Duration
R1042 - RAMUCIRUMAB [10 MG/ ML; 50 ML; SOL INJ; FRS]-6 (Months)

Object of the Contract

Object of the Contract
Supplies Acquisition 
Alameda Prof Hernâni Monteiro Paranhos Porto Área Metropolitana do Porto PORTUGAL  
33600000-6 - Pharmaceutical products
 
 
 

Scheduling

Scheduling
7/12/2024 10:16 AM (UTC +1 hour)
 
9/4/2023 10:07 AM (UTC +1 hour)
 
7/18/2024 5:00 PM (UTC +1 hour)
 

Financial Settings

Financial Settings
No 

Contract Documents

Contract Documents
Document NameDescriptionDoc Classification
Convite_AQ_CPA2023491_ULSSJ.pdfConvite_AQ_CPA2023491_ULSSJ.pdfDownload
Anexo_I_Mapa_QT_QA_CPA 2023491.xlsxAnexo_I_Mapa_QT_QA_CPA 2023491.xlsxDownload

Object of contract

No 
No 

Legal, economic, financial and technical information

No 

Questionnaire

Questionnaire
1
Lot Title
Section for Lot - R1042 - RAMUCIRUMAB [10 MG/ ML; 50 ML; SOL INJ; FRS]
Base Price
38.112,800000

1.1   Bill of Quantities  *  
This price list has extra requirements. Make sure everything is completed, under each article line.

Item Code Description Quantity Unit
R1042 RAMUCIRUMAB [10 MG/ ML; 50 ML; SOL INJ; FRS] 22,000000 NXTWY.UMT.3
Buyer Comment: 500165602 | Lilly Portugal - Produtos Farmacêuticos, Lda. | CPA:2023491/112/0018 | NºAIM:5635560;
TOTAL (The amounts shown do not include VAT)

Evaluation

Evaluation
Vision

Avaliação

Definir modelo de avaliação
Modalidade de avaliação
Método de Avaliação
Divulgar critérios de avaliação

Critérios da Avaliação

1 - R1042 - RAMUCIRUMAB [10 MG/ ML; 50 ML; SOL INJ; FRS]

Critérios da Avaliação

Descrição
Tipo de Fator
Peso (%)
1.PricePreço100%

Normas de desempate

Definir normas de desempate?

Public Messages

Public Messages
TypeReferenceSubjectDate
No items found...